Activated polyamine catabolism leads to low cholesterol levels by enhancing bile acid synthesis |
| |
Authors: | Eija Pirinen Helena Gylling Paula Itkonen Nagendra Yaluri Sami Heikkinen Marko Pietilä Teemu Kuulasmaa Maija Tusa Marc Cerrada-Gimenez Jussi Pihlajamäki Leena Alhonen Juhani Jänne Tatu A. Miettinen Markku Laakso |
| |
Affiliation: | 1. Department of Medicine, University of Kuopio, P.O. Box 1777, 70211, Kuopio, Finland 2. Department of Biotechnology and Molecular Medicine, Biocenter Kuopio, A.I.Virtanen Institute for Molecular Sciences, University of Kuopio, P.O. Box 1627, 70211, Kuopio, Finland 3. Department of Clinical Nutrition, University of Kuopio, P.O. Box 1627, 70211, Kuopio, Finland 4. Division of Internal Medicine, Department of Medicine, University of Helsinki, 700, 00029, Helsinki, Finland
|
| |
Abstract: | ![]() Transgenic mice with activated polyamine catabolism due to overexpression of spermidine/spermine N1-acetyltransferase (SSAT) have significantly reduced plasma total cholesterol levels. In our study, we show that low cholesterol levels were attributable to enhanced bile acid synthesis in combination with reduced cholesterol absorption. Hepatic cholesterol 7α-hydroxylase (CYP7A1), the rate-limiting enzyme catalyzing the conversion of cholesterol to bile acids, plays an important role in the removal of excess cholesterol from the body. We suggest that by reducing activity of Akt activated polyamine catabolism increased the stability and activity of peroxisome proliferator-activated receptor γ co-activator 1α, the critical activator of CYP7A1. This is supported by our finding that the treatment with SSAT activator, N 1,N 11-diethylnorspermine, reduced significantly the amount of phosphorylated (active) Akt in HepG2 cells. In summary, activated-polyamine catabolism is a novel mechanism to regulate bile acid synthesis. Therefore, polyamine catabolism could be a potential therapeutic target to control hepatic CYP7A1 expression. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|